This was also the case when identifying HER2-null status (score 0 or 1 + in < 1% of tumor cells) or by evaluating the presence of some tumor cells with score 3 + in < 10% within an obvious HER2low tumor. This evidence concerns the gene ERBB2 and neoplasm.